"So, for semaglutide, there's some preclinical evidence showing that this medication has neuro-protective effects and is also anti-inflammation, which can address a lot of risk factors associated with Alzheimer's disease." This means GLP-1 medications may not only lower blood sugar to reduce the risk for Alzheimer's disease, but they may also play a role in reducing neuro-inflammation
Both programs combine prescription medications with behavioral coaching, but they differ significantly in cost, medication options, and support structure
Tirzepatide is a dual GLP-1 and GIP receptor agonistfundamentally different from semaglutide, which targets GLP-1 alone
Our staff will guide you on whats best for your stage of care
If you only have a few pounds to lose, you may have been told that GLP-1 medications may not be the best option for you